Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials

REITH C., Blackwell L., EMBERSON J., PREISS D., Spata E., Davies K., HALLS H., Harper C., HOLLAND L., WILSON K., Humphrey R., Roddick A., Cannon C., Davis BR., Durrington PN., Goto S., Hitman GA., Hovingh GK., Koenig W., Krane V., LANDRAY MJ., MIHAYLOVA B., Newman C., Probstfield JL., Sabatine MS., Sattar N., Schwartz GG., Tonkin AM., White HD., Armitage J., Keech A., Simes J., Collins R., Baigent C., Collaboration CTT.